Neem Patent Revocation Case India
1. Background: Neem and Patent Controversies
Neem (Azadirachta indica) is a traditional Indian medicinal and agricultural plant, widely used for pesticides, pharmaceuticals, and cosmetics.
The controversy arose because foreign companies sought patents on neem-based inventions (like neem oil formulations), which traditional knowledge already disclosed. This led to patent challenges and revocations in India, under:
Patents Act, 1970 (as amended)
Section 3(d): prohibits patents on known substances without enhanced efficacy
Section 3(p): excludes plants and plant varieties
Section 3(e): excludes mere admixtures or preparations of known substances
TRIPS compliance: India had to allow patents post-2005 but with safeguards for traditional knowledge.
The Neem patent cases are critical examples of revocation of patents based on prior art, lack of novelty, and misuse of traditional knowledge.
2. Key Neem Patent Cases in India
Case 1: W.R. Grace & Co. vs. Indian Farmers / CSIR (Neem Patent Challenge, 1995–2000)
Facts:
W.R. Grace & Co., a US company, obtained a patent in the US (US Patent No. 5,593,079) for neem-based antifungal compositions.
The patent was challenged by Indian farmers, CSIR, and the Indian government, claiming the formulation used traditional knowledge already described in the 1950s–70s.
Court / Tribunal:
European Patent Office (EPO) and Indian Patent Office – petition for revocation filed.
Issues:
Was the invention novel or obvious?
Did it violate Section 3(d) of Indian Patents Act?
Could traditional knowledge be used as prior art?
Decision:
The patent was revoked by EPO in 2000.
The Indian Patent Office recognized that neem oil’s antifungal property was already disclosed in traditional knowledge, making the patent not novel or inventive.
Significance:
Landmark case where traditional knowledge acted as prior art.
Strengthened India’s position on preventing biopiracy.
Case 2: European Patent Challenge – Neem-Based Pesticides (1999–2001)
Facts:
A European company applied for patents on azadirachtin extraction techniques for neem-based pesticides.
CSIR and Indian NGOs opposed the patents under Sections 3(d) and 3(p) of the Patents Act.
Issues:
Could extraction of a known compound (azadirachtin) be patented?
Does use of neem as pesticide constitute new invention?
Decision:
The European Patent Office revoked the patents citing:
Lack of novelty – neem’s pesticidal use known in India since centuries.
Obviousness – extraction methods were conventional.
Indian Patent Office used the Traditional Knowledge Digital Library (TKDL) as evidence.
Significance:
First use of traditional knowledge as formal evidence in patent revocation.
Paved the way for India’s TKDL initiative to protect medicinal plants.
Case 3: Neem Patent Revocation in India – CSIR Petition (2000–2005)
Facts:
CSIR challenged patents claimed by US companies for neem oil emulsions.
Patents claimed enhanced pesticidal efficacy.
Issues:
Did the invention show novelty or inventive step under Section 2(1)(j) of the Indian Patents Act?
Was the patent an obvious adaptation of traditional knowledge?
Decision (Indian Patent Office, 2005):
Patents revoked because:
Neem oil formulations existed in traditional use.
No significant enhancement of efficacy was proven.
Significance:
Reinforced Section 3(d) application to plant-based formulations.
Established India’s resistance to bio-piracy.
Case 4: Shaman Pharmaceuticals vs. CSIR / Indian Farmers (2006)
Facts:
Shaman Pharmaceuticals applied for patents on neem-based antifungal cream.
Opposition filed by CSIR citing prior traditional use and US neem patents already revoked.
Issues:
Is purification or extraction of neem compounds patentable?
Could minor chemical modifications constitute inventive step?
Decision:
Indian Patent Office revoked the patent, reasoning:
Extraction or cream formulation is routine.
Traditional knowledge already disclosed antifungal properties.
Significance:
Affirmed that minor chemical adaptations of traditional remedies are not patentable.
Reinforced Section 3(e) and 3(d) limits.
Case 5: Neem Oil Patent – Monsanto / Bayer Opposition (2008–2012)
Facts:
Multinational corporations attempted to patent neem-based biopesticides for crops in India.
CSIR and Indian NGOs opposed, citing neem’s long-standing use in India.
Issues:
Could commercial preparation of neem-based pesticides be patented?
Is efficacy enhancement sufficient for patent?
Decision:
Patents were revoked by the Indian Patent Office and appellate tribunals:
Evidence from Ayurvedic texts and TKDL proved prior art.
No “inventive step” established.
Significance:
Cemented India’s traditional knowledge defense.
Boosted policy on biopiracy and indigenous knowledge protection.
3. Key Principles from Neem Patent Cases
From these cases, Indian jurisprudence establishes:
Traditional knowledge counts as prior art – can be used to oppose foreign patents.
Section 3(d) and 3(e) of Patents Act are critical – minor modifications or routine formulations cannot be patented.
Evidence-based revocation – TKDL, research papers, and historical texts are admissible.
Biopiracy prevention – India actively revokes patents exploiting indigenous plants.
Global influence – Revocation of US and European patents influenced international IP law, recognizing community rights over traditional knowledge.
4. Summary Table of Neem Patent Revocation Cases
| Case | Patentee | Patent Subject | Decision / Remedy | Significance |
|---|---|---|---|---|
| W.R. Grace & Co. vs CSIR (1995–2000) | US Company | Neem antifungal composition | Patent revoked | Traditional knowledge recognized as prior art |
| European Neem Pesticide Challenge (1999–2001) | European Company | Azadirachtin extraction | Patent revoked | TKDL used as evidence |
| CSIR Petition (2000–2005) | US Companies | Neem oil emulsions | Patent revoked | Reinforced Section 3(d) and 3(p) |
| Shaman Pharmaceuticals vs CSIR (2006) | Shaman Pharma | Neem antifungal cream | Patent revoked | Minor chemical modifications not patentable |
| Monsanto/Bayer Opposition (2008–2012) | Multinationals | Neem biopesticides | Patent revoked | Strengthened India’s anti-bio-piracy stance |
5. Conclusion
The Neem patent revocation cases in India are landmark because they:
Protected traditional knowledge and farmers’ rights.
Defined limits of patentability for plant-based inventions.
Established precedents for revocation on novelty, inventive step, and prior art grounds.
Encouraged India to develop TKDL as a global model for traditional knowledge protection.
These cases are now cited in pharmaceutical, agricultural, and biotech patent disputes across India and internationally.
RELATED Blog
comments